Could an antidepressant be better at treating Covid-19 than Merck's new, expensive pill? Plus, lots of pushback from parents expected as vaccines are approved for younger kids.
The On Deadline Podcast · Audacy
Audio is streamed directly from the publisher (serve.castfire.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
New research shows that a widely available antidepressant could be even more effective than a new pill from Merck at treating Covid-19. And it's much less expensive.
Speaking of that pill, Merck will allow a nonprofit group to manufacture it for low and middle income countries. But it won't allow for a generic option.
The FDA is expected to give final approval to Pfizer's vaccine for 5 to 11 year old kids later this week. How much resistance will we see from parents?
Yet another thing made worse by the pandemic: Childhood obesity.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices